Drug Profile
Research programme: dermatitis therapeutic - Abiogen
Alternative Names: KPV; MSH 11-13 monomerLatest Information Update: 17 Mar 2008
Price :
$50
*
At a glance
- Originator Abiogen Pharma
- Class
- Mechanism of Action Melanocyte stimulating hormone stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Dermatitis